Sorafenib induces tumor-suppressive autophagy in the parental HCC cells but induces the phosphorylation of Akt followed by mTOR and causes protective autophagy in sorafenib-resistant HCC cells [35]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.